OS Therapies Incorporated (NYSEAM: OSTX)
Health Care · Biotechnology · US
$1.55
-4.32% today · -21.7% 1Y
OS Therapies Incorporated (NYSEAM: OSTX) operates in the Biotechnology industry within the Health Care sector. The company is valued at $74.72M and employs 5 people.
Over the last twelve months the share price has lost 21.7%, trading between 1.15 and 2.25.
Tweenvest scores OS Therapies Incorporated across four factors: quality 20/100, value 50/100. Its strongest factor is value.
OSTX price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $74.72M
- Revenue (TTM)
- —
- P/E
- —
- EPS
- -1.05
- Dividend yield
- —
- Beta (5Y)
- -0.64
- 52-week high
- $2.25
- 52-week low
- $1.15
- Avg volume (3M)
- —
- Shares outstanding
- 46.13M
- Employees
- 5
- Next earnings
- —
About OS Therapies Incorporated
OS Therapies Incorporated, a clinical stage biopharmaceutical company, focuses on the identification, development, and commercialization of treatments for osteosarcoma and other solid tumors in the United States. Its pipeline includes OST-HER2, an off-the-shelf immunotherapy for osteosarcoma patients; and OST-tunable drug conjugate (OST-tADC), an antibody-drug conjugate (ADC) silicone dioxide linker technology, with a plug-and-play platform that features tunable pH sensitive silicone linkers. OS Therapies Incorporated was incorporated in 2018 and is based in Grasonville, Maryland.
- ISIN
- US68764Y2072
- Founded
- 2018
- Listed since
- Aug 1, 2024
- Exchange
- NYSE American LLC
- Currency
- USD
Other Biotechnology companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| Covalon Technologies Ltd.TSXV: COV | $77.11M | CA$3.82 | -4.02% |
| Sensorion SAENXTPA: ALSEN | $76.66M | €6.54 | -1.06% |
| CORESTEMCHEMON Inc.KOSDAQ: A166480 | $76.25M | ₩2,315.00 | +8.94% |
| MedPacto, Inc.KOSDAQ: A235980 | $75.59M | ₩2,970.00 | +5.88% |
| Gain Therapeutics, Inc.NasdaqGM: GANX | $74.63M | $1.67 | -2.34% |
| Gwo Xi Stem Cell Applied Technology Co. , LtdTPEX: 6704 | $74.40M | NT$24.70 | +12.53% |
| Vaxcell-Bio Therapeutics Co., Ltd.KOSDAQ: A323990 | $74.00M | ₩4,285.00 | +1.78% |
| MAIA Biotechnology, Inc.NYSEAM: MAIA | $72.38M | $1.18 | -0.84% |
Figures last refreshed Oct 4, 2026.